Refractory epilepsy: mechanisms and solutions

Expert Review of Neurotherapeutics
Patrick Kwan, Martin J Brodie

Abstract

Pharmacoresistance remains a major challenge in epilepsy management. The availability of ten new antiepileptic drugs since the late 1980s has not dramatically improved the outcome of refractory epilepsy. This article provides an overview of the contemporary understanding of epilepsy and the limitation of current treatment modalities, discusses putative biological mechanisms of medical intractability and reviews some of the novel strategies under investigation to overcome the challenge of pharmacoresistance.

References

Nov 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·J W Sander, S D Shorvon
Feb 7, 1998·Science·C BiervertO K Steinlein
Jun 1, 1997·Seminars in Cancer Biology·A H Schinkel
Oct 8, 1999·British Journal of Pharmacology·C MartinR Callaghan
Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie
Apr 12, 2000·Epilepsy Research·A G SteinR S Fisher
Feb 22, 2001·Annual Review of Physiology·D A McCormick, D Contreras
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·A HuberD Boison
Jul 13, 2001·Pharmacology & Therapeutics·P KwanM J Brodie
Aug 4, 2001·The New England Journal of Medicine·S WiebeUNKNOWN Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group
Feb 28, 2002·Current Medicinal Chemistry·Carmen Avendaño, J Carlos Menéndez
Mar 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Wolfgang Löscher, Heidrun Potschka
Apr 12, 2002·Current Pharmaceutical Design·Sandor Sólyom, István Tarnawa
Aug 3, 2002·CNS Drugs·Robert S Fisher, Jet Ho
Sep 25, 2002·Neurology·Thomas R Henry
Oct 29, 2002·Annals of Neurology·Kristl VonckJacques Caemaert
Jan 29, 2003·Neurology·A T BergS S Spencer
Apr 1, 2003·Annals of Neurology·Stefan RemyHeinz Beck
Apr 11, 2003·The New England Journal of Medicine·Asra SiddiquiSanjay M Sisodiya
Apr 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Hilary Thomas, Helen M Coley

❮ Previous
Next ❯

Citations

Jan 26, 2008·The Neurologist·Juan Carlos Sánchez AlvarezJosé María Serratosa Fernández
Feb 27, 2007·Epilepsia·Graeme Sills, Martin Brodie
Sep 25, 2012·Journal of Veterinary Internal Medicine·K R MuñanaK L Mealey
Oct 17, 2006·Drugs·Patrick Kwan, Martin J Brodie
Jan 25, 2011·CNS Drugs·Linda J Stephen, Martin J Brodie
Apr 27, 2013·Future Neurology·Michael Wong
Apr 17, 2014·Australasian Physical & Engineering Sciences in Medicine·Somayeh Raiesdana, Soleyman Esmaeilzadeha
Oct 14, 2009·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Karl O Nakken, Erik Taubøll
Jun 7, 2013·Expert Review of Neurotherapeutics·Michael Wong
Nov 19, 2011·Expert Review of Neurotherapeutics·Markus Rauchenzauner, Gerhard Luef
May 29, 2008·Expert Review of Neurotherapeutics·Michael Wong
Feb 9, 2007·Expert Review of Neurotherapeutics·Stavros M Hadjiloizou, Blaise F D Bourgeois
Jan 1, 2009·Expert Opinion on Drug Discovery·Doru Georg Margineanu, Henrik Klitgaard
Sep 19, 2007·Expert Opinion on Emerging Drugs·Patrick Kwan, Martin J Brodie
Jan 21, 2015·Pharmacology, Biochemistry, and Behavior·Elham GoudarziIran Goudarzi
Apr 24, 2012·Neuroscience·M Wong, D Guo
Jun 15, 2011·Epilepsy & Behavior : E&B·Sridhar SunderamIvan Osorio
Mar 1, 2011·Neuroscience Letters·Sharon S McDaniel, Michael Wong
Feb 9, 2016·Expert Review of Neurotherapeutics·Anna Jeong, Michael Wong
Mar 17, 2009·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Ramon Edmundo D Bautista, Juan G Ochoa
May 23, 2008·Brain, Behavior, and Immunity·Annamaria VezzaniTeresa Ravizza
May 20, 2008·Lancet Neurology·Stephan U Schuele, Hans O Lüders
Mar 11, 2008·Brain & Development·Hee Hwang, Ki Joong Kim
Jan 19, 2008·Trends in Neurosciences·Wolfgang LöscherUwe Heinemann
Feb 17, 2007·European Journal of Medicinal Chemistry·Hans-Joachim LankauChris Rundfeldt
Mar 16, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Antonio LeoMaurizio Elia
Nov 29, 2015·Neurosurgery Clinics of North America·Robert E GrossDaniel L Drane
Sep 15, 2015·Bioorganic & Medicinal Chemistry Letters·Tomoyuki TanakaYoshiki Miura
Mar 29, 2014·Basic & Clinical Pharmacology & Toxicology·Ekta SinghManMohan Mehndiratta
Apr 7, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Rita CitraroGiovambattista De Sarro
Jan 15, 2013·Pharmacology, Biochemistry, and Behavior·Giovany Michely Pinto da CruzGlauce Socorro de Barros Viana
Feb 5, 2011·Seizure : the Journal of the British Epilepsy Association·Wolfgang Löscher
Nov 8, 2011·Epilepsy Research·Doru Georg Margineanu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.